Results 31 to 40 of about 65,176 (294)

Tumor associated antigens in diagnosis of serous effusions [PDF]

open access: yes, 1988
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W.   +4 more
core   +1 more source

Evaluation of some serum biochemical parameters of humans exposed to burnt tire emissions

open access: yesJournal of Applied Sciences and Environmental Management, 2018
Evaluation of some serum biochemical parameters of humans who were exposed to burnt tire emissions (singeing process) was carried out in this study. Eighty (80) healthy adult males were recruited for the study after their consents were sought.
L.C. Chuku   +2 more
doaj   +1 more source

Tumor markers in breast cancer - European Group on Tumor Markers recommendations [PDF]

open access: yes, 2005
Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer.
Einarsson, Roland   +10 more
core   +1 more source

Prognostic significance of osteopenia in patients with colorectal cancer: A retrospective cohort study

open access: yesAnnals of Gastroenterological Surgery, 2021
Aim We examined the prognostic impact of osteopenia on the long‐term outcomes of patients with colorectal cancer after laparoscopic colectomy along with other nutritional factors, including sarcopenia or the Glasgow Prognostic Score.
Teppei Kamada   +9 more
doaj   +1 more source

CEA, CYFRA 21-1, NSE, and ProGRP in the diagnosis of lung cancer: a multivariate approach [PDF]

open access: yes, 2008
We retrospectively studied the single and combined diagnostic value of carcinoembryonic antigen (CEA), cytokeratin fragment 19 (CYFRA 21-1), neuron specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP), which were routinely analysed in ...
Gruber, Christine   +4 more
core   +1 more source

Characteristics of carcinoembryonic antigen-producing colorectal cancers: A population based study [PDF]

open access: yesArchive of Oncology, 2019
Objectives: Serum carcinoembryonic antigen is a tumor marker often found to be elevated in colorectal cancer patients. Elevated carcinoembryonic antigen has been strongly associated with poor prognosis.
Groover Sarah   +5 more
doaj  

Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases

open access: yesThe International Journal of Biological Markers, 2019
Background: Several prognostic factors were proposed to improve early detection of recurrence after liver resection of metastases of colorectal cancer.
Felice Giuliante   +7 more
doaj   +1 more source

Occult mucin-producing urothelial-type adenocarcinoma of the prostate with elevated serum levels of carcinoembryonic antigen and carbohydrate antigen 19-9: Report of an autopsy-proven case

open access: yesUrology Case Reports, 2019
Mucin-producing urothelial-type adenocarcinoma of the prostate (MPUAP) is a rare, aggressive neoplasm thought to originate from the prostatic urethral urothelium.
Keisuke Nonaka   +10 more
doaj   +1 more source

The prognostic value of postoperative tumor marker conversion for gastric cancer [PDF]

open access: yesKorean Journal of Clinical Oncology, 2020
Purpose Preoperative positivity of serum tumor markers has been associated with poor long-term survival among patients with gastric cancer. However, there have been a considerable number of patients who have experienced a normalization of tumor markers ...
Jeongju Noh, Ki Bum Park, Oh Kyoung Kwon
doaj   +1 more source

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy